Nilabha Mukherjea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nilabha Mukherjea has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Preetam Bhardwaj
Research and Development, Vidyuta, A Lohum Group of Company, Kasna Industrial Area Greater Noida 201310, Uttar Pradesh, India
2 shared publications - Utkarsh Chadha
Department of Materials Science and Engineering, Faculty of Applied Sciences and Engineering, University of Toronto
2 shared publications - Anusuiya Bora
Bioinformatics Working Group, Burnet Institute, Melbourne, Australia
1 shared publication Arghya Chakravorty
School of Bio Science and Technology, Vellore Institute of Technology, Vellore, Tamilnadu—632014, India
1 shared publication- Evelyn Li
Department of Materials Science and Engineering, Faculty of Applied Sciences and Engineering, University of Toronto, Toronto, Ontario ON M5S 2Z9, Canada
1 shared publication Ishi Gupta
School of Electronics Science and Engineering (SENSE), Vellore Institute of Technology, Vellore, Tamilnadu—632014, India
1 shared publication
Latest Publications
- Open Access
- 1 March 2025
- Published by The Electrochemical Society in ECS Journal of Solid State Science and Technology
- Vol. 14 (3) , 034005
Current Progress in Black Phosphorus Nanomaterials: Exploring Electrochemical, Biomedical, and Biosensor Applications
Black phosphorus nanomaterials (BPN), including 2D phosphorene, 1D nanoribbons, and 0D BP quantum dots (BPQDs) exhibit superior electronic performance, remarkable biocompatibility, and tunable bandgap energy. They present immense potential in a variety of fields involving electronics, energy storage, biosensing, and biomedical applications. Despite these favorable characteristics, there are some significant obstacles impeding the widespread adoption of BPN, which includes their degradation in moisture, light, and oxygen-rich environments, difficulties in achieving scalable, high-quality BPN production and instability in electrocatalysis further limit their practical applications. Future work will revolve around optimizing BPN synthesis, thoroughly examining the degradation mechanisms, maintaining BPN stability, and comprehending the biosafety of BP analogues and polymers. In particular, the review suggests exploring BP-metal/metal oxide nanostructure composites, as well as conducting additional research on BPQD-based nanocomposites for biological imaging and drug delivery. Development of efficient anti-degradation strategies, advancement of synthesis techniques, and a deeper understanding of the characteristics and potential applications of BPN will unlock their immense potential across various fields.
- 1 March 2025
- Published by The Electrochemical Society in ECS Journal of Solid State Science and Technology
- Vol. 14 (3) , 034005
Open AccessCurrent Progress in Black Phosphorus Nanomaterials: Exploring Electrochemical, Biomedical, and Biosensor Applications
Black phosphorus nanomaterials (BPN), including 2D phosphorene, 1D nanoribbons, and 0D BP quantum dots (BPQDs) exhibit superior electronic performance, remarkable biocompatibility, and tunable bandgap energy. They present immense potential in a variety of fields involving electronics, energy storage, biosensing, and biomedical applications. Despite these favorable characteristics, there are some significant obstacles impeding the widespread adoption of BPN, which includes their degradation in moisture, light, and oxygen-rich environments, difficulties in achieving scalable, high-quality BPN production and instability in electrocatalysis further limit their practical applications. Future work will revolve around optimizing BPN synthesis, thoroughly examining the degradation mechanisms, maintaining BPN stability, and comprehending the biosafety of BP analogues and polymers. In particular, the review suggests exploring BP-metal/metal oxide nanostructure composites, as well as conducting additional research on BPQD-based nanocomposites for biological imaging and drug delivery. Development of efficient anti-degradation strategies, advancement of synthesis techniques, and a deeper understanding of the characteristics and potential applications of BPN will unlock their immense potential across various fields.
- Open Access
- 1 May 2023
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 170 (5) , 057520
Review—Magneto-Electrochemical-based Biosensors Devices for Recognition of Tumour Vesicles from Blood Plasma
Today, cancer is analyzed after it has metastasized throughout the body. This understanding demands earlier identification of cancer to enable better opportunities for a cure. Viable and well-defined strategies to discover cancer and clinical determination are the need of the hour. Biosensors are devices intended to recognize a particular natural analyte by recognizing an organic element (i.e., protein, DNA, RNA) to produce the signals as an electrical signature that can be distinguished and investigated. The utilization of biosensors in disease recognition and observation holds immense potential in diagnosis and treatment. Biosensors can detect cancer biomarkers and decide drug adequacy at different objective destinations. Innovations attributed to biosensors can give a quick and exact location, dependable imaging of cancer cells, observe angiogenesis and disease metastasis, and have the capacity to decide the adequacy of anticancer chemotherapy for specialists. This review briefly summarizes the growing utilization of magneto-electrochemical biosensors as indicative devices and some of its future uses of biosensor innovation.
- 1 May 2023
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 170 (5) , 057520
Open AccessReview—Magneto-Electrochemical-based Biosensors Devices for Recognition of Tumour Vesicles from Blood Plasma
Today, cancer is analyzed after it has metastasized throughout the body. This understanding demands earlier identification of cancer to enable better opportunities for a cure. Viable and well-defined strategies to discover cancer and clinical determination are the need of the hour. Biosensors are devices intended to recognize a particular natural analyte by recognizing an organic element (i.e., protein, DNA, RNA) to produce the signals as an electrical signature that can be distinguished and investigated. The utilization of biosensors in disease recognition and observation holds immense potential in diagnosis and treatment. Biosensors can detect cancer biomarkers and decide drug adequacy at different objective destinations. Innovations attributed to biosensors can give a quick and exact location, dependable imaging of cancer cells, observe angiogenesis and disease metastasis, and have the capacity to decide the adequacy of anticancer chemotherapy for specialists. This review briefly summarizes the growing utilization of magneto-electrochemical biosensors as indicative devices and some of its future uses of biosensor innovation.